You are here

XORTX Therapeutics Inc.

XORTX Therapeutics Inc.
Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
XRX
CSE Index: 
Currency: 

XORTX Therapeutics Inc. is a pharmaceutical company with two clinically advanced products in development – XRx-008 for Autosomal Dominant Polycystic Kidney Disease (ADPKD), XRx-101 for Coronavirus / COVID-19 infection and XRx-225 is a pre-clinical stage program for Type 2 Diabetic Nephropathy (T2DN). XORTX is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. At XORTX Therapeutics, we are dedicated to developing medications to improve the quality of life and future health of patients.  Additional information on XORTX Therapeutics is available at www.xortx.com.

You are here

XORTX Therapeutics Inc. (XRX)

SEDAR Information

Company Info

Address
4000, 421 – 7th Avenue SW
Calgary, AB T2P 4K9
Canada
Phone
(403) 455 7717
Email
adavidoff@xortx.com
Website
http://xortx.com
Listing date
Wednesday, September 30, 2015
Transfer Agent
TSX Trust Company
Auditor
Smythe LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
9,728,687
Reserved for Issuance: 
2,362,168
Total equity shares, as if converted: 
12,090,855

Company Officers

Allen Davidoff, President and Chief Executive Officer
Charlotte May, Corporate Secretary
W. Bruce Rowlands, Chairman
Paul J. Van Damme, Director
Ian Klassen, Director
Jacqueline Le Saux, Director
William Farley, Director
Amar Keshri, Chief Financial Officer
Dr. Stephen Haworth, Chief Medical Officer

Bulletins

04/11/2021

2021-1109 - Delist - XORTX Therapeutics Inc. (XRX)

le 4 novembre/November 2021

At the request of the company the common shares of XORTX Therapeutics Inc. will be delisted at market close on November 4, 2021.

The Company’s common shares will continue to trade on the TSX Venture Exchange.

___________________________

À la demande de la société, les actions ordinaires de XORTX Therapeutics Inc. seront radiées à la clôture du marché le 4 novembre 2021.

Les actions ordinaires de la Société continueront d'être négociées à la Bourse de croissance TSX.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2021-12-09-Nation-Builder-of-the-Year-Award-2021_Website.jpg

2021 Nation Builder of the Year Award

Thursday, December 9, 2021 -
12:00pm to 1:00pm
JM_DigitalBanners_VRIC_Website.jpg

Vancouver Resource Investment Conference (VRIC)

Sunday, January 16, 2022 - 8:30am to Monday, January 17, 2022 - 5:30pm
Can-Securities-Exchange_PDAC22_web-740x374_Website.jpg

90th Annual PDAC Convention 2022

Monday, March 7, 2022 to Friday, March 11, 2022